Pharmacokinetics of cefoperazone in patients with neoplastic disease (Q35670676)

9 August 2017

Pharmacokinetics of cefoperazone in patients with neoplastic disease (English)

1 reference

9 August 2017

1 reference

A W Maksymiuk

1

1 reference

9 August 2017

B M LeBlanc

2

1 reference

9 August 2017

N S Brown

3

1 reference

9 August 2017

D H Ho

4

1 reference

9 August 2017

G P Bodey

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 June 1981

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

1 reference

9 August 2017

19

1 reference

9 August 2017

6

1 reference

9 August 2017

1037-1041

1 reference

Clinical pharmacology of moxalactam in patients with malignant disease

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

In vitro evaluation of cefoperazone

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Pharmacokinetics of Cefazolin Compared with Four Other Cephalosporins

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Proceedings: Causes of death in cancer patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Effect of cephalothin on growth patterns of micro-organisms

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Pharmacokinetics of Cephalosporins in Patients with Normal or Reduced Renal Function

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine Cephalosporin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

Description and classification of the newer cephalosporins and their relationships with the established compounds

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181604

12 July 2018

Identifiers

DOI

10.1128/AAC.19.6.1037

1 reference

9 August 2017

1 reference

9 August 2017

1 reference